Crossmark

Alzheimer’s disease severity and its association with patient and caregiver quality of life in Japan: results of a community-based survey

Crossref DOI link: https://doi.org/10.1186/s12877-018-0831-2

Published Online: 2018-06-14

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Montgomery, William

Goren, Amir

Kahle-Wrobleski, Kristin

Nakamura, Tomomi

Ueda, Kaname
Funding

Funding for this research was provided by:

Eli Lilly and Company
License Information

Text and Data Mining valid from 2018-06-14
More Information

Article History

Received: 10 January 2018

Accepted: 29 May 2018

First Online: 14 June 2018

Ethics approval and consent to participate

: The original NHWS patient protocol and questionnaire were reviewed and approved by Essex Institutional Review Board (Lebanon, New Jersey, USA). The follow-up survey was reviewed and approved by Pearl Institutional Review Board (Indianapolis, Indiana, USA). All participants provided their explicit informed consent online, given that this was an internet-based questionnaire.

: William Montgomery, Kristin Kahle-Wrobleski, Tomomi Nakamura, and Kaname Ueda were full-time employees of Eli Lilly and Company at the time of the study. Amir Goren is an employee of Kantar Health, which conducted this study with funding from Eli Lilly, and manages the National Health and Wellness Survey.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.